Chloroplast (Talk | contribs) |
Chloroplast (Talk | contribs) |
||
Line 130: | Line 130: | ||
</header> | </header> | ||
− | <p> | + | <p><table> |
+ | <thead><tr class="tableizer-firstrow"><th>Part Number</th><th>Part Description</th><th>Characterised?</th><th>Link</th></tr></thead><tbody> | ||
+ | <tr><td>BBa_K1897019</td><td>p70-34-ALR-Terminator </td><td>Yes</td><td>http://parts.igem.org/Part:BBa_K1897019</td></tr> | ||
+ | <tr><td>BBa_K1897020</td><td>p70-32-ALR-Terminator </td><td>Yes</td><td>http://parts.igem.org/Part:BBa_K1897020</td></tr> | ||
+ | <tr><td>BBa_K1897021</td><td>p70-33-ALR-Terminator </td><td>Yes</td><td>http://parts.igem.org/Part:BBa_K1897021</td></tr> | ||
+ | <tr><td>BBa_K1897022</td><td>p62-34-ALR-Terminator </td><td>Yes</td><td>http://parts.igem.org/Part:BBa_K1897022</td></tr> | ||
+ | <tr><td>BBa_K1897023</td><td>p62-32-ALR-Terminator </td><td>Yes</td><td>http://parts.igem.org/Part:BBa_K1897023</td></tr> | ||
+ | <tr><td>BBa_K1897024</td><td>p62-33-ALR-Terminator </td><td>Yes</td><td>http://parts.igem.org/Part:BBa_K1897024</td></tr> | ||
+ | <tr><td>BBa_K1897025</td><td>J23100-34-ALR-Terminator </td><td>Yes</td><td>http://parts.igem.org/Part:BBa_K1897025</td></tr> | ||
+ | <tr><td>BBa_K1897026</td><td>J23100-32-ALR-Terminator </td><td>Yes</td><td>http://parts.igem.org/Part:BBa_K1897026</td></tr> | ||
+ | <tr><td>BBa_K1897027</td><td>J23100-33-ALR-Terminator </td><td>Yes</td><td>http://parts.igem.org/Part:BBa_K1897027</td></tr> | ||
+ | <tr><td>BBa_K1897028</td><td>p70-33-sfGFP-Terminator </td><td>Yes</td><td>http://parts.igem.org/Part:BBa_K1897028</td></tr> | ||
+ | <tr><td>BBa_K1897029</td><td>p62-33-sfGFP-Terminator </td><td>Yes</td><td>http://parts.igem.org/Part:BBa_K1897029</td></tr> | ||
+ | </tbody></table></p> | ||
<hr> | <hr> | ||
Line 138: | Line 151: | ||
<header> | <header> | ||
<!--h3></h3--> | <!--h3></h3--> | ||
− | <p class="medium">RIOT | + | <p class="medium">RIOT RESPONDER</p> |
</header> | </header> | ||
<p align=justify>NUS_Singapore is a start-up company formed by a group of undergraduates from the National University of Singapore (NUS), interested in developing new diagnostic tools for cancer using synthetic biology technology. Our start-up uses synthetic biological technology to create the Regulated Invasive Organism Targeting System (RIOT System) which consists of three components: The RIOT Sensor, RIOT Responder and the RIOT Invader. Taken together, this system employs a modular concept of integrating different genetic circuits that serve individual functions with crosstalk capability. For the full and detailed business plan of our start-up, please <a href="https://static.igem.org/mediawiki/2016/7/70/T--NUS_Singapore--BusinessPlanFinal.pdf" style="font-weight: bold;">CLICK HERE.</a></p><br/> | <p align=justify>NUS_Singapore is a start-up company formed by a group of undergraduates from the National University of Singapore (NUS), interested in developing new diagnostic tools for cancer using synthetic biology technology. Our start-up uses synthetic biological technology to create the Regulated Invasive Organism Targeting System (RIOT System) which consists of three components: The RIOT Sensor, RIOT Responder and the RIOT Invader. Taken together, this system employs a modular concept of integrating different genetic circuits that serve individual functions with crosstalk capability. For the full and detailed business plan of our start-up, please <a href="https://static.igem.org/mediawiki/2016/7/70/T--NUS_Singapore--BusinessPlanFinal.pdf" style="font-weight: bold;">CLICK HERE.</a></p><br/> |
Revision as of 04:04, 18 October 2016
Parts Registry
RIOT Sensor
Part Number | Part Description | Characterised? | Link |
---|---|---|---|
BBa_K1897019 | p70-34-ALR-Terminator | Yes | http://parts.igem.org/Part:BBa_K1897019 |
BBa_K1897020 | p70-32-ALR-Terminator | Yes | http://parts.igem.org/Part:BBa_K1897020 |
BBa_K1897021 | p70-33-ALR-Terminator | Yes | http://parts.igem.org/Part:BBa_K1897021 |
BBa_K1897022 | p62-34-ALR-Terminator | Yes | http://parts.igem.org/Part:BBa_K1897022 |
BBa_K1897023 | p62-32-ALR-Terminator | Yes | http://parts.igem.org/Part:BBa_K1897023 |
BBa_K1897024 | p62-33-ALR-Terminator | Yes | http://parts.igem.org/Part:BBa_K1897024 |
BBa_K1897025 | J23100-34-ALR-Terminator | Yes | http://parts.igem.org/Part:BBa_K1897025 |
BBa_K1897026 | J23100-32-ALR-Terminator | Yes | http://parts.igem.org/Part:BBa_K1897026 |
BBa_K1897027 | J23100-33-ALR-Terminator | Yes | http://parts.igem.org/Part:BBa_K1897027 |
BBa_K1897028 | p70-33-sfGFP-Terminator | Yes | http://parts.igem.org/Part:BBa_K1897028 |
BBa_K1897029 | p62-33-sfGFP-Terminator | Yes | http://parts.igem.org/Part:BBa_K1897029 |
RIOT RESPONDER
NUS_Singapore is a start-up company formed by a group of undergraduates from the National University of Singapore (NUS), interested in developing new diagnostic tools for cancer using synthetic biology technology. Our start-up uses synthetic biological technology to create the Regulated Invasive Organism Targeting System (RIOT System) which consists of three components: The RIOT Sensor, RIOT Responder and the RIOT Invader. Taken together, this system employs a modular concept of integrating different genetic circuits that serve individual functions with crosstalk capability. For the full and detailed business plan of our start-up, please CLICK HERE.
RIOT Invader
In cancer treatment, specificity, sensitivity and reliability of diagnosis is the gold criteria of any diagnostic method. The RIOT System employs a novel method of cancer detection, relying on spatial markers that are intrinsic to the tumour microenvironment. Two types of spatial markers are used to increase specificity and ensure that only cancerous cells are targeted. The first spatial marker would be the elevated concentration of lactate usually found around tumours due to the Warburg effect. The second marker would be the detection of CD44v6, a cell surface marker that is upregulated on a variety of cancers. These spatial markers were specially chosen to circumvent a common problem in cancer research, where heterogeneity in different types of cancers results in the lack of a specific diagnostic for a variety of cancers. As elevated lactate concentration is ubiquitous among solid tumours and CD44v6 is present in different types of cancers, our RIOT System has the potential to be a diagnostic that can be applied to multiple cancers, which is advantageous in the current market where broad spectrum diagnostics for cancer are currently lacking. Furthermore, the utility of RIOT System can extend beyond just being a diagnostic and can be modified to deliver a drug payload, potentially acting as both a diagnostic and therapeutic.
Based on our preliminary market analysis of the diagnostics industry, our proposed RIOT System stands out as one of the few in vivo options available for cancer detection. Current cancer diagnostics rely mainly on in vitro laboratory tests for detection of cancer biomarkers (e.g. blood, urine), imaging scans (e.g. CT scans, MRI) or physical examinations to detect the tumour. Thus, our RIOT System offers a radically different diagnostic option that sets itself apart from the current diagnostics.